Multiple Sclerosis

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal - Michigan State Medical Society

• Publication date

  2007-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-2006-956758PMID 13222063
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lectures on Diseases of the Nervous System

  1880cited by this paper
• Anatomie pathologique du corps humain

  year unknowncited by this paper

• From usability to clinical impact: a systematic review of digital technologies for motor rehabilitation in multiple sclerosis.

  2026cites this paper
• Transcranial magnetic stimulation outcomes as biomarkers of multiple sclerosis disease progression: A structured literature review.

  2026cites this paper
• The emerging paradigms of SETD family enzymes as epigenetic regulators of the immune response in inflammatory diseases

  2026influential citation
• The Diet–Multiple Sclerosis Connection: Oxidative Stress and Emerging Mechanisms

  2026cites this paper
• CHI3L1 Expression in Neutrophils and Plasma of Multiple Sclerosis Patients: Implications for Pathogenesis and a Potential Biomarker

  2026cites this paper
• Predictors of initiating high-efficacy vs. platform therapies as first-line disease-modifying treatment in multiple sclerosis

  2026cites this paper
• Circulating immune cells and risk of multiple sclerosis: A Mendelian randomization analysis

  2026cites this paper
• Ferroptosis and Alzheimer’s disease: unraveling the molecular mechanisms and therapeutic opportunities

  2026cites this paper
• Dynamics and Impact of Repopulating Microglia Following Oligodendroglial Damage

  2026cites this paper
• The potential application of a ketogenic diet in type 1 diabetes mellitus and multiple sclerosis

  2026cites this paper
• Effects of disease modifying therapy on cognitive proficiency in pediatric-onset multiple sclerosis (POMS).

  2026cites this paper
• Obesity, Nutrition and the Multiple Sclerosis Risk in Adolescents

  2026cites this paper
• Housing needs for people with multiple sclerosis: a rapid review

  2026cites this paper
• Heated tobacco and cigarette smoke modulate CD4 + T cell activation and neuroinflammation in a context-dependent manner

  2026cites this paper
• A visual reinterpretation of the 2024 McDonald criteria for multiple scleroris.

  2026cites this paper
• The Hidden Players in Multiple Sclerosis Nutrition: A Narrative Review on the Influence of Vitamins, Polyphenols, Salt, and Essential Metals on Disease and Gut Microbiota

  2026cites this paper
• Comorbidity and modifiable risk factors in multiple sclerosis

  2026cites this paper
• Illness identity and its association with self-esteem, hope, social support among patients with multiple sclerosis

  2026cites this paper
• The role of dentists in the recognition of neurodegenerative and systemic conditions with neurological involvement.

  2026cites this paper
• Effect of cerebellar high frequency repetitive transcranial magnetic stimulation on the balance of MS patients with ataxia

  2026cites this paper
• Reprogramming brain-resident macrophages: from disease drivers to therapeutic allies in neurological disorders.

  2026cites this paper
• miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.

  2026cites this paper
• Hospitalizations and Mortality Due to Multiple Sclerosis in Brazil (2018–2025): An Epidemiological Assessment within the Unified Health System

  2026cites this paper
• Medication trajectories among persons with Multiple Sclerosis in a Quebec Birth Cohort

  2026cites this paper
• Early Prognostic Factors in Multiple Sclerosis: Clinical and Therapeutic Implications

  2026cites this paper
• A proof-of-concept study on the relationship between lifetime Estrogen exposure, menopausal transition, and neurodegeneration in women with multiple sclerosis

  2026cites this paper
• Small “Non-Coding RNAs” (sncRNAs) and their Role in Gene Repression, PostTranscriptional Gene Regulation and Therapeutics. Part-III: PIWI Interacting RNA (piRNA); its Biogenesis, Role in Post-Transcriptional Gene Silencing (PTGS) and Therapeutic Applications

  2026cites this paper
• Oligodendrocytes Are Active Participants in the Pathogenesis of Multiple Sclerosis and Its Animal Models.

  2026influential citation
• Real world predictors of hypogammaglobulinemia and serious infections in patients receiving ocrelizumab or ofatumumab for the treatment of multiple sclerosis: The REPLACE-MS study

  2026cites this paper
• Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry

  2026cites this paper
• Translational molecular imaging and drug development in multiple sclerosis

  2026cites this paper
• Autophagy-NLRP3 Inflammasome Crosstalk in Microglia: A Therapeutic Target for Multiple Sclerosis

  2026cites this paper
• Chinese neuroimmunological disease (NIDBase) cohort study: cohort profile

  2026cites this paper
• The Evolving and Often Overlooked Potential of Self-Management in Rehabilitation Counseling: The Example of Multiple Sclerosis Self-Management

  2026cites this paper
• Diffusion tensor imaging along the perivascular space and disease progression in people with multiple sclerosis: a 5-year longitudinal MRI study

  2026cites this paper
• Association of treatment decision with personality, coping strategies and impulsivity in patients with multiple sclerosis

  2026cites this paper
• Glutathione and neurodegenerative diseases: immunopharmacological implications

  2026cites this paper
• Recruitment of the multiple sclerosis cohort within the European Mobilise-D clinical validation study—lessons learnt, baseline demographics and clinical characteristics

  2026cites this paper
• Disrupted Vitamin D Signaling and Metabolism in Neurodevelopmental and Neurodegenerative Disorders

  2026influential citation
• EBV Dysregulation Is Associated With Immune Imbalance in Multiple Sclerosis

  2026cites this paper
• Therapeutic potential of TAM receptors in autoimmune diseases: insights from original studies

  2026cites this paper
• Integrating climate change education into physiatry: A critical need to protect persons with disability

  2026cites this paper
• Serum neurofilament light chain and glial fibrillary acidic protein predicting multiple sclerosis after clinically isolated syndrome

  2026cites this paper
• Monitoring cognition in multiple sclerosis via adaptive smartphone games-first insights from a validation study.

  2026cites this paper
• Higher dietary choline and betaine intakes are associated with lower likelihood of central nervous system demyelination in Australian women

  2026cites this paper
• Diagnostic pathways and barriers in multiple sclerosis in Zambia: A qualitative study

  2026cites this paper
• Linking Mechanisms of Lipoic Acid to Multiple Sclerosis: A Narrative Review

  2026cites this paper
• A Systematic Review of the Content Validity of Self-Management Outcome Measurement Instruments for Youth With Multiple Sclerosis Transitioning to Adult Care.

  2026cites this paper
• Swimming exercise modulates pro-inflammatory cytokines in a mouse model of multiple sclerosis

  2026cites this paper
• Association of cytokine levels with treatment duration and patient family history in Egyptian multiple sclerosis patients

  2026cites this paper
• Neuroprotective Role of Cannabinoid CB1 and GPR55 Receptors in a Cell Model of Multiple Sclerosis

  2026cites this paper
• SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study.

  2026cites this paper
• An updated review of the economic burden of multiple sclerosis: direct and indirect costs

  2026cites this paper
• Exploring the Association of Interleukin 13 Polymorphism (rs20541) and Serum Lipocalin 2 with Risk and Disability in Multiple Sclerosis

  2026cites this paper
• Chronic lesion expansion as an imaging biomarker in multiple sclerosis.

  2026cites this paper
• The CNS Meninges and the Synovial Joint: Parallel Immunological Structures in Autoimmune Disease

  2026cites this paper
• Pain in multiple sclerosis: clinical phenotypes and therapeutic strategies - a narrative review.

  2026cites this paper
• Volumetric MRI Markers of Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis: Cerebellar White Matter Loss, Pallidum Atrophy, and Choroid Plexus Enlargement.

  2026cites this paper
• Silencer variants are key drivers of gene up-regulation in Alzheimer’s disease

  2026cites this paper
• Choroid plexus enlargement associates with serum neurofilament and predicts relapse-free progression in multiple sclerosis.

  2026cites this paper
• Motion-robust myelin imaging in MRI using 1D projection gating

  2026cites this paper
• Zuo Gui Wan Promotes Remyelination in Multiple Sclerosis by Attenuating MAPK-Mediated Microglial M1 Polarization, an Integrated Network Pharmacology and Experimental Validation Study

  2026cites this paper
• Engineering exosomes for targeted neurodegenerative therapy: innovations in biogenesis, drug loading, and clinical translation

  2026cites this paper
• Label-free plasmonic biosensors for neurodegenerative disease diagnosis: Progress and perspectives

  2026cites this paper
• Over-Reliance on Prior Expectations in Relapsing-Remitting Multiple Sclerosis

  2026cites this paper
• Cannabis sativa L.: An integrative review of its botanical diversity, phytochemistry, and therapeutic promise

  2026cites this paper
• Cerebrospinal fluid metabolites and multiple sclerosis: A two-sample Mendelian randomization study

  2026cites this paper
• Mitochondrial function of peripheral lymphocytes: role on multiple sclerosis clinical subtypes.

  2026cites this paper
• Depletion of Microglia Increases Cortical Oligodendrocyte Density During Remyelination

  2026cites this paper
• Antibody-drug conjugates: From oncological milestones to emerging non-oncological applications.

  2026cites this paper
• Improving dynamic balance in relapsing-remitting MS: insights from robotic-assisted rehabilitation therapy

  2026cites this paper
• Integrated multi-omics analysis identifies microbial and metabolic signatures and drivers of CNS autoimmunity

  2026cites this paper
• Neurotrauma and multiple sclerosis: the silent catalyst – a systematic review and meta-analysis

  2026cites this paper
• Interleukin-9 Regulates NF-kB-Mediated Activation of Astrocytes in Multiple Sclerosis Brain

  2026cites this paper
• Oxylipin Biomarkers of Auto-Oxidation Are Associated with Antioxidant Micronutrients and Multiple Sclerosis Disability

  2026cites this paper
• Multiple sclerosis and the risk of dementia: a real-world, nationwide cohort study

  2026cites this paper
• Molecular Gardening for Neuroinflammation via Nose‐to‐Brain Delivery: A Ca2+ Responsive DNA Nanocage‐Hydrogel System With Neuron Targeting and STING Inhibiting

  2026cites this paper
• Bioactive Phytochemicals in Experimental Models of Multiple Sclerosis: Mechanisms, Efficacy, and Translational Potential

  2026cites this paper
• Diverse Ligands for Mycobacterial CYP124 Identified from Plant and Marine Compounds

  2026cites this paper
• Impact of sleep quality on cognitive function and overall quality of life in Egyptian patients with multiple sclerosis

  2026cites this paper
• Astrocyte CB1 receptors drive blood-brain barrier disruption in central nervous system inflammatory disease

  2026cites this paper
• Tumefactive Demyelination Mimicking Intracranial Neoplasms: A Case Series

  2026cites this paper
• Post-contrast Susceptibility Weighted Imaging in Multiple Sclerosis MRI Improves the Detection of Enhancing Lesions

  2025cites this paper
• Outcomes in patients with multiple sclerosis and solid organ cancers treated with immune checkpoint inhibitors

  2025cites this paper
• Headache and Facial Pain in Multiple Sclerosis: A Narrative Review

  2025cites this paper
• Transcriptomic profiling identifies ferroptosis and NF-κB signaling involved in α-dimorphecolic acid regulation of microglial inflammation

  2025cites this paper
• Imaging Correlates of Plaque Location and Cognitive Dysfunction in Multiple Sclerosis

  2025cites this paper
• Combination therapy dramatically promotes remyelination

  2025cites this paper
• Can supplementation with antioxidants improve cognitive functions in patients with multiple sclerosis? A literature review

  2025cites this paper
• The epidemiology, pathology and pathogenesis of MS: Therapeutic implications

  2025cites this paper
• Evaluating emotional regulation and comorbidities in multiple sclerosis: Insights from a unified protocol treatment case study

  2025cites this paper
• Enhancing remyelination in multiple sclerosis via M1 muscarinic acetylcholine receptor

  2025cites this paper
• Assessment of the impact of reconstitution therapies—cladribine tablets and alemtuzumab—on the atrophy progression among patients with relapse-remitting multiple sclerosis

  2025cites this paper
• Leptin and Leptin Signaling in Multiple Sclerosis: A Narrative Review

  2025cites this paper
• Novel Cell Models to Study Myelin and Microglia Interactions

  2025influential citation
• Mechanistic target of rapamycin/blood-testes barrier mechanism mediates acceleration of sperm epigenetic aging by environmental factors

  2025cites this paper
• Portuguese Consensus for the Evaluation of the Multiple Sclerosis Treatment Response: A Delphi Panel

  2025cites this paper
• B‐Cell and T‐Cell Populations in Peripheral Blood Linked to Ocrelizumab Treatment Efficacy in Multiple Sclerosis

  2025cites this paper
• Investigating mechanisms underlying the development of paralysis symptom in a model of MS

  2025cites this paper
• Climate change and multiple sclerosis: Clinical challenges and strategies

  2025cites this paper